[Skip to Content]
[Skip to Content Landing]
December 10, 2008

Silver-Coated Endotracheal Tubes and Patient Outcomes in Ventilator-Associated Pneumonia

JAMA. 2008;300(22):2605-2606. doi:10.1001/jama.2008.760

To the Editor: In their study of the North American Silver-Coated Endotracheal Tube (NASCENT) randomized trial, Dr Kollef and colleagues1 concluded that silver-coated endotracheal tubes reduced the incidence of ventilator-associated pneumonia (VAP) by 36% compared with uncoated tubes. The evidence they present, however, is more suggestive of an effect on endobronchial colonization than on clinically meaningful invasive disease.

First Page Preview View Large
First page PDF preview
First page PDF preview